Related Experiment Video
Updated: Mar 15, 2026

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
Published on: June 27, 2025
Portal Vein Thrombosis: Recent Advance
1Department of Gastroenterology, General Hospital of Shenyang Military Area, No. 83 Wenhua Road, Shenyang, 110840, China. xingshunqi@126.com.
Portal vein thrombosis is a serious liver vascular condition. This review covers recent advances in its epidemiology, causes, treatment, and outlook.
Area of Science:
- Hepatology
- Vascular Medicine
- Gastroenterology
Background:
- Portal vein thrombosis (PVT) is a critical vascular disorder affecting the liver.
- PVT can lead to severe complications, including liver failure and hemorrhage.
Purpose of the Study:
- To provide a comprehensive overview of recent advancements in portal vein thrombosis.
- To discuss the epidemiology, etiology, current management strategies, and prognosis of PVT.
Main Methods:
- Literature review of recent studies on portal vein thrombosis.
- Synthesis of current knowledge on PVT epidemiology and risk factors.
- Analysis of contemporary treatment modalities and their outcomes.
Main Results:
- Recent studies highlight evolving trends in PVT epidemiology and associated risk factors.
- Advances in anticoagulation and interventional therapies have improved PVT management.
- Prognosis of PVT is increasingly understood, with outcomes dependent on underlying causes and treatment efficacy.
Conclusions:
- Effective management of portal vein thrombosis requires a multidisciplinary approach.
- Continued research is essential to further refine treatment strategies and improve patient outcomes for PVT.
- Understanding the latest advancements in PVT is crucial for clinicians managing liver vascular disorders.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis IV: Nursing Management
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins

